Has David Gremse received payments from drug or device companies?

Yes. Drug and device makers reported $2,936 in general payments to David Gremse across 60 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Gremse did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Gremse come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Gremse

Pediatric Gastroenterology · Mobile, ALNPI 1750369468

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 53.7% of the total. Reporting peaked in 2024 at $1,740 and has fallen 78.4% since, to $376 in 2025.

$2,936in general payments, 2019–2025

Across 60 payments — averaging $48.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Takeda Pharmaceuticals U.S.A., Inc.$2K
Sanofi$270
Regeneron Healthcare Solutions, Inc.$217
AbbVie$160
Sanofi-aventis U.S. LLC$120
Phathom Pharmaceuticals, Inc.$115
plus $478 from 12 others

$551,967in research payments, 2019–2025

Across 317 payments — averaging $1741.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Takeda Pharmaceuticals U.S.A., Inc.$336K
Ferring International Pharmascience Center US$147K
QOL Medical, LLC$42K
Phathom Pharmaceuticals, Inc.$24K
Astrazeneca AB$4K

What the payments were for

Consulting fees$1,50651%
Food & beverage$1,40948%
Education$211%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Takeda Pharmaceuticals U.S.A., Inc.	12	$1,576
Sanofi	7	$270
Regeneron Healthcare Solutions, Inc.	8	$217
AbbVie	5	$160
Sanofi-aventis U.S. LLC	1	$120
Phathom Pharmaceuticals, Inc.	1	$115
Alcresta Therapeutics, Inc.	4	$85
Mirum Pharmaceuticals, Inc.	3	$60
Nestle Healthcare Nutrition Inc.	3	$59
Rhythm Pharmaceuticals, Inc.	2	$56
Eisai Inc.	3	$51
Travere Therapeutics, Inc.	4	$36
Cumberland Pharmaceuticals, Inc.	2	$27
Ipsen Biopharmaceuticals, Inc	1	$24
Cranial Technologies, Inc	1	$22
Sandoz	1	$19
Ironwood Pharmaceuticals, Inc	1	$19
Albireo Pharma, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TZIELD$120
VOQUEZNA$115
Humira$104

How this compares

$2,936 in reported general payments places this provider in the 85th percentile of 29 pediatric gastroenterology providers in Alabama.

See all pediatric gastroenterology providers in Alabama →

Other pediatric gastroenterology in Mobile

Osman AltunMobile$1K
Jenelle FernandezMobile$1K
Kathryn WilliamsMobile$1K
Ananthasekar PonnambalamMobile$401
Daniel Preud HommeMobile$81
Karen CrissingerMobile$19
Sandeep GuptaBirmingham$52K
Traci JesterBirmingham$6K
Meredith HitchDothan$6K
David WillcuttsBirmingham$5K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →